Published in Curr Opin HIV AIDS on January 01, 2010
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology (2016) 0.92
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS Med (2013) 0.89
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. J Acquir Immune Defic Syndr (2015) 0.82
Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis. AIDS (2015) 0.79
Paediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group. Trop Med Int Health (2013) 0.77
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother (2009) 1.47
Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J (2009) 1.32
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis (2013) 1.06
Applying the information-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: a qualitative study. AIDS Patient Care STDS (2010) 1.03
Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age. J Allergy Clin Immunol (2010) 1.00
Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 0.99
Characterizing HIV manifestations and treatment outcomes of perinatally infected adolescents in Asia. Pediatr Infect Dis J (2014) 0.99
HIV and Hepatitis B coinfection among perinatally HIV-infected Thai adolescents. Pediatr Infect Dis J (2012) 0.98
HIV disclosure and its effect on treatment outcomes in perinatal HIV-infected Thai children. AIDS Care (2014) 0.90
Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks. Pediatr Infect Dis J (2008) 0.89
A feasibility study of motivational interviewing for health risk behaviors among Thai youth living with HIV. J Assoc Nurses AIDS Care (2012) 0.88
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther (2008) 0.85
Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women. Menopause (2012) 0.84
Motivational interviewing targeting risk behaviors for youth living with HIV in Thailand. AIDS Behav (2013) 0.83
Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression. AIDS Res Hum Retroviruses (2012) 0.83
Prevalence of human leukocyte antigen-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir use. Pediatr Infect Dis J (2013) 0.83
Prevalence of vitamin D deficiency among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. Pediatr Infect Dis J (2013) 0.81
The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2011) 0.81
Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922. Pediatr Infect Dis J (2015) 0.79
Nephelometry determined serum immunoglobulin isotypes in healthy Thai children aged 2-15 years. Microbiol Immunol (2012) 0.79
Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDS (2014) 0.79
Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents. AIDS (2016) 0.78
Long-term lopinavir/ritonavir monotherapy in HIV-infected children. Pediatr Infect Dis J (2013) 0.78
Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia. Pediatr Infect Dis J (2016) 0.78
Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children. Pediatr Infect Dis J (2015) 0.77
Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission. J Acquir Immune Defic Syndr (2016) 0.77
Immunoglobulin values in healthy Thai children aged ≤ 24 months determined by nephelometry. Asian Pac J Allergy Immunol (2013) 0.77
High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents. J Acquir Immune Defic Syndr (2016) 0.76
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents. Pediatr Infect Dis J (2017) 0.75
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children. AIDS Behav (2013) 0.75
Association between lymphocyte and monocyte subsets and cognition in children with HIV. AIDS Res Ther (2014) 0.75
Motivational interviewing targeting risky sex in HIV-positive young Thai men who have sex with men. Arch Sex Behav (2014) 0.75
Premenstrual Disorders Among Perinatally HIV-Infected Adolescents. J Acquir Immune Defic Syndr (2015) 0.75
First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand. J Acquir Immune Defic Syndr (2017) 0.75
Rilpivirine as a Treatment for HIV-infected Antiretroviral-naïve Adolescents: Week 48 Safety, Efficacy, Virology and Pharmacokinetics. Pediatr Infect Dis J (2016) 0.75
First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand. J Acquir Immune Defic Syndr (2017) 0.75
Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease. J Med Assoc Thai (2007) 0.75
Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium. J Acquir Immune Defic Syndr (2017) 0.75